Wuhan Biocause Pharmaceutical Development Co., Ltd
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- China
- Registered address
- Building 1, Hi-Tech Industrial Zone, Zhuankou Economic Technology Development Area, Wuhan, Hubei 430058, China (CHN)
- Operations here
- api manufacture
- FDA identifiers
- FEI 3004202226 · DUNS 544983661
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2025-03-14
- VAIDrug Quality Assurance2018-08-24
- VAIDrug Quality Assurance2016-07-22
- VAIDrug Quality Assurance2014-02-28
- VAIDrug Quality Assurance2010-07-23
Drugs this plant is listed as making
1 distinct drugs across 2 products name this site in their FDA label.
- Milrinone Lactate in DextroseHospira, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.